Off-Label Uses of Ranibizumab and Aflibercept for Age-Related Macular Degeneration in Turkey

PURPOSE: To evaluate the clinical and demographic aspects of off-label drug use applications for age-related macular degeneration (AMD) in Turkey. METHODS: Applications for off-label drug use in the treatment of AMD to the Turkish Medicines and Medical Devices Agency (TITCK) in 2018 were retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Yilmaz, Mevlut, Citirik, Mehmet, Rahmanlar, Hanife, Alkan, Ali, Gursoz, Hakki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481980/
https://www.ncbi.nlm.nih.gov/pubmed/37680284
http://dx.doi.org/10.4103/joco.joco_323_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481980/
https://www.ncbi.nlm.nih.gov/pubmed/37680284
http://dx.doi.org/10.4103/joco.joco_323_22

Ejemplares similares